Market outlook of liver cirrhosis therapeutics
According to the liver cirrhosis therapeutics industry analysis, Technavio’s research analyst predicts the global liver cirrhosis therapeutics market to grow moderately at a CAGR of over 4% during the forecast period. Liver diseases such as cirrhosis, hepatitis, liver cancer, and nonalcoholic fatty liver disease have become prevalent among the population worldwide, hence the consumption of medications that manage liver diseases is likely to increase, which in turn will drive the growth of the liver cirrhosis therapeutics market.
Increased public awareness of liver cirrhosis is also leading to the growth of the liver cirrhosis therapeutics market value. The early detection of infections is important in reducing disease progression. For instance, the early screening and diagnosis of hepatitis C and B infections can prevent or reduce the extent of liver damage. Many government and nongovernmental organizations have been organizing awareness campaigns, seminars, summits, and fundraising events to educate people about the diseases and therapeutic measures available. These awareness programs are leading to more people opting for therapeutic drugs for treatment, increasing drug consumption and their revenues.
Segmentation by type of the liver cirrhosis therapeutics market
- Alcoholic cirrhosis
- Postnecrotic cirrhosis
- Biliary cirrhosis
- Cardiac cirrhosis
Alcoholic cirrhosis is the most common type of liver cirrhosis and occupied the largest share in the liver cirrhosis therapeutics market with a market share of about 60% during 2015. Factors such as increased prevalence of liver diseases and change in the lifestyle patterns are expected to propel the market growth. Lifestyle factors such as obesity, smoking, intake of alcohol and dietary sodium have been found to increase the risk of liver cirrhosis. According to a 2011 study, nearly half of all the liver disease cases occur due to alcohol and tobacco-related health hazards.
Geographical segmentation and analysis of the liver cirrhosis therapeutics market
In this market research report, Technavio’s analysts have envisaged the Americas to be the largest market for liver cirrhosis therapeutics during the forecast period. High incidences of liver diseases such as liver cirrhosis in regions like the US and Canada and hepatitis in Latin America is a significant factor, which is expected to result in the region’s market share of about 49% by 2020.
Competitive landscape and key vendors
The existence of high unmet medical needs, such as the adverse effects of drugs, presents a vast opportunity for vendors to develop molecules that have better efficacy and safety profiles for the treatment of liver cirrhosis. This will create a strong competition among small and large players in the liver cirrhosis therapeutics market who will compete on the basis of price, quality, and innovation.
The leading vendors in the market are -
- Gilead Sciences
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- Roche
Other prominent vendors in the market include Bristol-Myers Squibb, Conatus Pharmaceuticals, Gwo Xi Stem Cell Applied Technology, Instituto Grifols, Intercept Pharmaceuticals, NGM Biopharmaceuticals, Norgine, Pharmicell, Salix Pharmaceuticals, and Stempeutics Research.
Key questions answered in the report include
- What will the liver cirrhosis therapeutics market size and the growth rate be in 2020?
- What are the key factors driving the global liver cirrhosis therapeutics market?
- What are the key liver cirrhosis therapeutics market trends impacting the growth of the market?
- What are the challenges to market growth?
- Who are the key vendors in the global liver cirrhosis therapeutics market?
- What are the market opportunities and threats faced by the vendors in the global liver cirrhosis therapeutics market?
- Trending factors influencing the market shares of the Americas, APAC, and Europe.
- What are the key outcomes of the five forces analysis of the global liver cirrhosis therapeutics market?
Technavio also offers customization on reports based on specific client requirement.
Related reports:
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
PART 05: Disease overview
- Understanding the disease
- Etiology
- Symptoms
- Pathophysiology
- Diagnosis
- Epidemiology
- Prevention
- Treatment
- Impact of alcohol consumption on liver cirrhosis
PART 06: Pipeline portfolio
- Information on pipeline candidates
- Clinical trials for liver cirrhosis
PART 07: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 08: Market segmentation by type of molecule
- Biologics
- Small molecules
PART 09: Market segmentation by types of liver cirrhosis
PART 10: Market segmentation by types of liver cirrhosis treatment
- Medications to treat causes of liver cirrhosis
- Medications to treat complications of liver cirrhosis
PART 11: Geographical segmentation
- Liver cirrhosis medication market in Americas
- Market overview
- Market size and forecast
- Liver cirrhosis medication market in EMEA
- Market overview
- Market size and forecast
- Liver cirrhosis medication market in APAC
- Market overview
- Market size and forecast
PART 12: Market drivers
- High prevalence of liver cirrhosis
- Advances in technology
- High unmet medical needs
- Changes in lifestyle
PART 13: Impact of drivers
PART 14: Market challenges
- Use of alternative therapies
- Adverse effects of drugs
- Poor patient adherence
- Stringent regulatory guidelines
PART 15: Impact of drivers and challenges
PART 16: Market trends
- Rise in public awareness
- Increase in R&D
- Use of off-label drugs
- Patient assistance programs
PART 17: Vendor landscape
- Competitive scenario
- F Hoffmann-La Roche
- GlaxoSmithKline
- Gilead Sciences
- Johnson & Johnson
- Merck
- Other prominent vendors
PART 18: Appendix
PART 19: Explore Technavio
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape